A consolidated, AI-driven view of financial strength across every rated company in this industry — ranked by Economic Capital Ratio, with the causal reasoning behind each score.
Aggregate ECR metrics across every ranked company, by year. Click a point to jump to that year.
Headline figures for this industry and year.
All 471 rated companies in US Pharma, 2023.
| #↑ | Company | Seal | Economic Capital Ratio | Trend |
|---|---|---|---|---|
| 1 |  Theravance Biopharma Inc | ★ Top rated | ▲ 192 | |
| 2 |  Chimerix INC | ★ Top rated | ▲ 400 | |
| 3 |  Opus Genetics Inc | ★ Top rated | ▲ 409 | |
| 4 |  Kiniksa Pharmaceuticals International plc | ★ Top rated | ▲ 238 | |
| 5 |  Xbiotech Inc | ★ Top rated | ▼ 1 | |
| 6 |  Zomedica Corp | ★ Top rated | ▲ 6 | |
| 7 |  ARS Pharmaceuticals Inc | ★ Top rated | ▲ 62 | |
| 8 |  Nuvation Bio Inc | ★ Top rated | ▲ 10 | |
| 9 | ESSA Pharma Inc | ★ Top rated | ▲ 8 | |
| 10 |  EQRx Inc | ★ Top rated | ▲ 69 | |
| 11 |  DICE Therapeutics Inc | ★ Top rated | ▲ 16 | |
| 12 | Nuvalent Inc | ★ Top rated | ▲ 8 | |
| 13 |  Tyra Biosciences Inc | ★ Top rated | ▼ 8 | |
| 14 |  SIGA Technologies INC | ★ Top rated | ▲ 34 | |
| 15 |  Xenon Pharmaceuticals Inc | ★ Top rated | ▲ 7 | |
| 16 | Rezolute Inc | ★ Top rated | ▲ 278 | |
| 17 |  Terns Pharmaceuticals Inc | ★ Top rated | ▲ 49 | |
| 18 | Design Therapeutics Inc | ★ Top rated | ▼ 12 | |
| 19 |  Karuna Therapeutics Inc | ★ Top rated | ▲ 45 | |
| 20 |  Morphic Holding Inc | ★ Top rated | ▲ 147 | |
| 21 |  Corcept Therapeutics INC | ★ Top rated | ▼ 10 | |
| 22 |  Anaptysbio INC | ★ Top rated | ▼ 13 | |
| 23 |  Astria Therapeutics Inc | ★ Top rated | ▲ 280 | |
| 24 |  Jazz Pharmaceuticals plc | ★ Top rated | ▲ 1 | |
| 25 |  Atossa Therapeutics INC | ★ Top rated | ▼ 10 |
How the RealRate model weighs this industry — feature impact, importance, and fit.
The Feature Distribution shows the main industry variables and the distribution of their impact on financial strength. The more important a variable, the broader the distribution. As the effects are calculated relative to the industry average, half of the companies have a positive effect (green) and half have a negative effect (red).
The Feature Importance Graph highlights the most important industry features for the industry. These variables have the greatest impact on financial health, shown as the last variable at the bottom of the causal graph.
The Regression Plot compares the forecasted company valuation with the observed stock market values. A positive correlation suggests that the model effectively explains market prices.
